Journal
Vascular Medicine
Publication Date
12-1-2023
Volume
28
Issue
6
First Page
571
Last Page
580
Document Type
Open Access Publication
DOI
10.1177/1358863X231199489
Rights and Permissions
van Overhagen H, Nakamura M, Geraghty PJ, et al. Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries. Vascular Medicine. 2023;28(6):571-580. doi:10.1177/1358863X231199489© The Author(s) 2023. Creative Commons License (CC BY-NC 4.0) This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Recommended Citation
van Overhagen, Hans; Geraghty, Patrick J; and et al., "Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries." Vascular Medicine. 28, 6. 571 - 580. (2023).
https://digitalcommons.wustl.edu/oa_4/2760
Additional Links
Supplemental material is available for this article at publisher site.
